ClearPoint Neuro CLPT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 62.3%+1.1pp | 61.4%+0.5pp | 61.3%+0.9pp | 60.4%+0.6pp | 61.2%+4.1pp | |
| Operating margin | -65.2%+2.1pp | -65.4%-2.5pp | -66.3%-4.5pp | -67.4%-1.3pp | -67.3%+12.8pp | |
| Net margin | -71.6%-7.1pp | -69.1%-8.8pp | -67.4%-7.8pp | -66.2%-2.1pp | -64.5%+14.3pp | |
| Returns | ||||||
| Return on equity | -149.7%-73.5pp | -95.6%-14.4pp | -103.1%-34.8pp | -85.7%-25.3pp | -76.2%-14.8pp | |
| Return on invested capital | -93%+86.2pp | -100.4%+89.1pp | -187%-35.9pp | -170.3%-39.4pp | -179.2%-62.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×-0.1× | 0.5×-0.2× | 0.7×0.0× | 0.6×0.0× | 0.8×+0.3× | |
| Liquidity | ||||||
| Current ratio | 5.8×+2.3× | 5.9×+2.7× | 6.4×+1.8× | 7.3×+4.5× | 3.5×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 3.4×+3.2× | 2.1×+1.9× | 2.3×+2.1× | 1.8×+1.4× | 0.2×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.64-11.6% | $0.99+5.3% | $0.56-46.9% | $0.70-40.3% | $0.72-46.9% | |
| Valuation | ||||||
| Market capitalization | $538.61M+69.2% | $406.96M-4.1% | $619.43M+100% | $328.72M+122% | $328.55M+79.1% | |
| Price / sales | 13.3×+3.4× | 11×-2.5× | 18×+7.9× | 9.8×+4.5× | 10.2×+3.2× | |
| Price / book | 28.6×+12.7× | 14.5×-2.2× | 39×+28.4× | 16.7×+12.1× | 16.4×+11.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ClearPoint Neuro's profit margins?
- ClearPoint Neuro (CLPT) runs a 62.3% gross margin and a -65.2% operating margin, with a -71.6% net margin.
- Where do ClearPoint Neuro's ratios come from?
- Every ratio is computed from ClearPoint Neuro's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
